Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1983 Jan;51(1):61–68.

Monocyte PGE2 secretion in Hodgkin's disease and its relation to decreased cellular immunity.

J Passwell, M Levanon, J Davidsohn, B Ramot
PMCID: PMC1536751  PMID: 6572580

Abstract

The secretion of PGE2 from monocytes of newly diagnosed patients with Hodgkin's disease (HD) was compared to that of patients in remission, who were not receiving either chemotherapy or radiotherapy, and normal controls. We found that monocyte monolayers of some patients, both newly diagnosed and those in remission, secreted markedly elevated levels of PGE2. The lymphocyte proliferative response to PHA was increased to a similar extent in both newly diagnosed patients and those in remission when cultured in the presence of indomethacin. PGE2 concentrations in the medium of mononuclear cultures correlated with the lymphocyte proliferative response to PHA (P less than 0.05). However, no correlation of monocyte PGE2 production with decreased E rosette forming lymphocytes, anergy or clinical stage could be demonstrated. We suggest that PGE2 secretion by monocytes is indicative of an 'activated' state of these cells. It is, however, unlikely that PGE2 is the only molecular species responsible for the decreased cellular immune function in HD. 'Activated' monocytes may be part of the immune response in this disease and may be responsible for the decreased cellular immunity.

Full text

PDF
66

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baird L. G., Kaplan A. M. Macrophage regulation of mitogen-induced blastogenesis. II. Mechanism of inhibition. Cell Immunol. 1977 Jan;28(1):36–50. doi: 10.1016/s0008-8749(77)80004-x. [DOI] [PubMed] [Google Scholar]
  2. Bonney R. J., Naruns P., Davies P., Humes J. L. Antigen-antibody complexes stimulate the synthesis and release of prostaglandins by mouse peritoneal macrophages. Prostaglandins. 1979 Oct;18(4):605–616. doi: 10.1016/0090-6980(79)90027-3. [DOI] [PubMed] [Google Scholar]
  3. Brandeis W. E., Tan C., Wang Y., Good R. A., Day N. K. Circulating immune complexes, complement and complement component levels in childhood Hodgkin's disease. Clin Exp Immunol. 1980 Mar;39(3):551–561. [PMC free article] [PubMed] [Google Scholar]
  4. Deshazo R. D., Ewel C., Londono S., Metzger Z., Hoffeld J. T., Oppenheim J. J. Evidence for the involvement of monocyte-derived toxic oxygen metabolites in the lymphocyte dysfunction of Hodgkin's disease. Clin Exp Immunol. 1981 Nov;46(2):313–320. [PMC free article] [PubMed] [Google Scholar]
  5. Edelson P. J., Cohn Z. A. Effects of concanavalin A on mouse peritoneal macrophages. I. Stimulation of endocytic activity and inhibition of phago-lysosome formation. J Exp Med. 1974 Nov 1;140(5):1364–1386. doi: 10.1084/jem.140.5.1364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Einstein L. P., Schneeberger E. E., Colten H. R. Synthesis of the second component of complement by long-term primary cultures of human monocytes. J Exp Med. 1976 Jan 1;143(1):114–126. doi: 10.1084/jem.143.1.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fischer A., Durandy A., Griscelli C. Role of prostaglandin E2 in the induction of nonspecific T lymphocyte suppressor activity. J Immunol. 1981 Apr;126(4):1452–1455. [PubMed] [Google Scholar]
  8. Fisher R. I., DeVita V. T., Jr, Bostick F., Vanhaelen C., Howser D. M., Hubbard S. M., Young R. C. Persistent immunologic abnormalities in long-term survivors of advanced Hodgkin's disease. Ann Intern Med. 1980 May;92(5):595–599. doi: 10.7326/0003-4819-92-5-595. [DOI] [PubMed] [Google Scholar]
  9. Fuks Z., Strober S., Bobrove A. M., Sasazuki T., McMichael A., Kaplan H. S. Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease. J Clin Invest. 1976 Oct;58(4):803–814. doi: 10.1172/JCI108532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gallin J. I., Sandler J. A., Clyman R. I., Manganiello V. C., Vaughan M. Agents that increase cyclic AMP inhibit accumulation of cGMP and depress human monocyte locomotion. J Immunol. 1978 Feb;120(2):492–496. [PubMed] [Google Scholar]
  11. Goodwin J. S., Bankhurst A. D., Messner R. P. Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell. J Exp Med. 1977 Dec 1;146(6):1719–1734. doi: 10.1084/jem.146.6.1719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Goodwin J. S., Bromberg S., Staszak C., Kaszubowski P. A., Messner R. P., Neal J. F. Effect of physical stress on sensitivity of lymphocytes to inhibition by prostaglandin E2. J Immunol. 1981 Aug;127(2):518–522. [PubMed] [Google Scholar]
  13. Goodwin J. S., Messner R. P., Bankhurst A. D., Peake G. T., Saiki J. H., Williams R. C., Jr Prostaglandin-producing suppressor cells in Hodgkin's disease. N Engl J Med. 1977 Nov 3;297(18):963–968. doi: 10.1056/NEJM197711032971802. [DOI] [PubMed] [Google Scholar]
  14. Goodwin J. S., Messner R. P. Sensitivity of lymphocytes to prostaglandin E2 increases in subjects over age 70. J Clin Invest. 1979 Aug;64(2):434–439. doi: 10.1172/JCI109480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gordon S., Todd J., Cohn Z. A. In vitro synthesis and secretion of lysozyme by mononuclear phagocytes. J Exp Med. 1974 May 1;139(5):1228–1248. doi: 10.1084/jem.139.5.1228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kaplan H. S. Hodgkin's disease: unfolding concepts concerning its nature, management and prognosis. Cancer. 1980 May 15;45(10):2439–2474. doi: 10.1002/1097-0142(19800515)45:10<2439::aid-cncr2820451003>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  17. Keller R. Major changes in lymphocyte proliferation evoked by activated macrophages. Cell Immunol. 1975 Jun;17(2):542–551. doi: 10.1016/s0008-8749(75)80058-x. [DOI] [PubMed] [Google Scholar]
  18. Kelly J. P., Johnson M. C., Parker C. W. Effect of inhibitors of arachidonic acid metabolism on mitogenesis in human lymphocytes: possible role of thromboxanes and products of the lipoxygenase pathway. J Immunol. 1979 Apr;122(4):1563–1571. [PubMed] [Google Scholar]
  19. Kurland J. I., Bockman R. Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages. J Exp Med. 1978 Mar 1;147(3):952–957. doi: 10.1084/jem.147.3.952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Leb L., Merritt J. A. Decreased monocyte function in patients with Hodgkin's disease. Cancer. 1978 May;41(5):1794–1803. doi: 10.1002/1097-0142(197805)41:5<1794::aid-cncr2820410522>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  21. Levine L., Gjtierrez Cernosek R. M., Van Vunakis H. Specificities of prostaglandins B 1 , F 1 , and F 2 antigen-antibody reactions. J Biol Chem. 1971 Nov 25;246(22):6782–6785. [PubMed] [Google Scholar]
  22. Passwell J. H., Dayer J. M., Merler E. Increased prostaglandin production by human monocytes after membrane receptor activation. J Immunol. 1979 Jul;123(1):115–120. [PubMed] [Google Scholar]
  23. Passwell J. H., Levanon M., Davidsohn J., Kohen F., Ramot B. The effect of human monocytes and macrophages on lymphocyte proliferation. Immunology. 1982 Sep;47(1):175–181. [PMC free article] [PubMed] [Google Scholar]
  24. Passwell J., Rosen F. S., Merler E. The effect of Fc fragments of IgG on human mononuclear cell responses. Cell Immunol. 1980 Jul 1;52(2):395–403. doi: 10.1016/0008-8749(80)90360-3. [DOI] [PubMed] [Google Scholar]
  25. Ramot B., Rosenthal E., Biniaminov M., Ben-Bassat I. Effect of levamisole, thymic humoral factor and indomethacin on e-rosette formation of lymphocytes in Hodgkin's disease. Isr J Med Sci. 1981 Apr;17(4):232–235. [PubMed] [Google Scholar]
  26. Schechter G. P., Soehnlen F. Monocyte-mediated inhibition of lymphocyte blastogenesis in Hodgkin disease. Blood. 1978 Aug;52(2):261–271. [PubMed] [Google Scholar]
  27. Stobo J. D., Kennedy M. S., Goldyne M. E. Prostaglandin E modulation of the mitogenic response of human T cells. Differential response of T-cell subpopulations. J Clin Invest. 1979 Nov;64(5):1188–1203. doi: 10.1172/JCI109572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Twomey J. J., Laughter A. H., Rice L., Ford R. Spectrum of immunodeficiencies with Hodgkin's disease. J Clin Invest. 1980 Oct;66(4):629–637. doi: 10.1172/JCI109898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Unanue E. R. The regulation of lymphocyte functions by the macrophage. Immunol Rev. 1978;40:227–255. doi: 10.1111/j.1600-065x.1978.tb00408.x. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES